ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years.

Christopher G Bunick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.